Xiangyang Xue

zhejiang-finland joint laboratory of gastrointestinal tumor metabolism and nutrition

H指数:34

被引数:4,397

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SH3GLB1 mediates tumor cell resistance to tyrosine kinase inhibitors by regulating mitophagy

SH3GLB1通过调控线粒体自噬介导肿瘤细胞对酪氨酸激酶抑制剂的耐药性

Cell Death & Disease

IF9.6

2026-10-270

OAAI

Molecular mechanisms and targets underlying immune evasion by human cytomegalovirus

人类巨细胞病毒通过免疫逃逸的分子机制与靶点

microbiology immunology and infection

IF0

2025-07-010

OAAI

Multi-omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study

MOLECULAR MEDICINE

IF6.4

2025-01-080

OAAI

Guided contrastive boundary learning for semantic segmentation

PATTERN RECOGNITION

IF7.6

2024-11-010

PRE

NEIL3 Upregulated by TFAP2A Promotes M2 Polarization of Macrophages in Liver Cancer via the Mediation of Glutamine Metabolism

DIGESTION

IF3.6

2024-09-270

PRE

RNA epigenetic modifications in digestive tract cancers: Friends or foes

PHARMACOLOGICAL RESEARCH

IF10.5

2024-08-011

OAAI

NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation (vol 12, 842, 2021)

CELL DEATH & DISEASE

IF9.6

2024-07-110

OAAI

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy

Elesclomol负载氧化铜纳米平台触发cuprotosis以增强抗肿瘤免疫治疗

ADVANCED SCIENCE

IF14.1

2024-03-0222

OAAI

Emerging roles of the epitranscriptome in parasitic protozoan biology and pathogenesis

Trends in Parasitology

IF6.6

2024-03-013

PRE

Construction of a prognostic model for colorectal adenocarcinoma based on Zn transport-related genes identified by single-cell sequencing and weighted co-expression network analysis

FRONTIERS IN ONCOLOGY

IF3.3

2023-09-260

OAAI

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-03-061

OAAI

Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-03-015

OAAI

RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges

WILEY INTERDISCIPLINARY REVIEWS-RNA

IF4.8

2023-02-2111

PRE

ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer

CELL DEATH & DISEASE

IF9.6

2023-02-1515

OAAI

Propensity score matching comparisons of postoperative complications and morbidity between digestive tract reconstruction methods after gastrectomy in gastric cancer patients with visceral obesity

FRONTIERS IN ONCOLOGY

IF3.3

2023-02-132

OAAI

A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-144

OAAI

Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-05-028

OAAI

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma

NSUN2促进鼻咽癌肿瘤进展和调节免疫浸润

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-2928

OAAI

Sustained expression of HPV16 E7 oncoprotein promotes p-AKT(Ser473)/p-Src(Tyr527) signaling to drive precancerous lesions to invasive cervical cancer

HPV16 E7癌蛋白的持续表达促进p-akt (Ser473)/p-src (Tyr527) 信号，将癌前病变驱动为浸润性宫颈癌

CARCINOGENESIS

IF2.9

2022-02-044

Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus

inflammation research

IF4.1

2022-02-011

Xiangyang Xue

个人简介

教育背景

工作经历

荣誉奖项

研究方向